Implementing a Stepped Care Model to Address Fear of Cancer Recurrence in Early Stage (0-II) Melanoma Patients - A Pilot Study

Not Applicable

Active, not recruiting

• Conditions: Melanoma; Fear of Cancer Recurrence; Cancer - Malignant melanoma; Mental Health - Anxiety; Mental Health - Other mental health disorders

• Registration Number: ACTRN12621000145808
• Lead Sponsor: Melanoma Centre for Research Excellence

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-02-12
• Last Update Posted: 13 February 2023

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 115

Inclusion Criteria

Diagnosis of stage 0, I or II melanoma.
Sufficient English and cognitive skills to independently read the Participant Information Sheet, Consent Form and study materials.
Able to give informed consent to participate in the study.
Sufficient hearing to participate in the psychotherapeutic telehealth sessions.

Exclusion Criteria

Diagnosis of stage III or IV (metastatic) melanoma.
Patients with high risk of melanoma but have never received a diagnosis of the disease.
Diagnosis of severe depression, psychotic illness or other serious psychiatric condition.
Significant cognitive and / or hearing impairment that would prevent understanding of Participant Information Statement, study materials and participation in telehealth sessions.

Study & Design

• Study Type: Interventional
• Study Design: Not specified